Ampicillin and Sulbactam for Injection, USP 3 grams per vial, Rx only, Manufactured for: Xellia Pharmaceuticals USA, LLC, Buffalo Grove, IL 60089, NDC 70594-082-02
Published May 24, 2023 · Recall initiated: May 15, 2023
Summary
FDA records drug Class II recall D-0602-2023, published May 24, 2023 and initiated May 15, 2023. Recalling firm: Astral SteriTech Private Ltd.; Status: Terminated; Reported quantity: 591,160 vials; Lot: All lots within expiry. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Astral SteriTech Private Ltd.
- Distributor
- Nationwide within the United States
- Lot
- All lots within expiry.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- India
Related recalls
- FDAAmpicillin and Sulbactam for Injection, USP 1.5 grams per vial, Rx only, Mfd for Meitheal PharmaceuticalsMay 24, 2023
- FDACeftriaxone for Injection, USP 10 grams per Pharmacy Bulk Package, Rx only, Manufactured for: XelliaMay 24, 2023
- FDAPiperacillin and Tazobactam for Injection, USP, 3.375 grams per vial, Rx only, Mfg. for: Piramal CriticalMay 24, 2023
- FDAPiperacillin and Tazobactam for Injection, USP 4.5 grams per vial, Rx only, Mfd for Meitheal PharmaceuticalsMay 24, 2023
- FDAAmpicillin and Sulbactam for Injection, USP 1.5 grams per vial, Rx only, Manufactured for: XelliaMay 24, 2023
- FDAAmpicillin and Sulbactam for Injection, USP 15 grams per Pharmacy Bulk Package, Rx only, Manufactured for:May 24, 2023
Questions about this recall
Was Ampicillin and Sulbactam for Injection, USP 3 grams per vial, Rx only, Manufactured for: Xellia Pharmaceuticals USA, LLC, Buffalo Grove, IL 60089, NDC 70594-082-02 recalled?
Yes. FDA published recall D-0602-2023 on May 24, 2023. Reported hazard: Lack of Assurance of Sterility
What should I do if I have this product?
Voluntary: Firm initiated · Letter